患有心脏病的儿童死亡原因:一个队列研究
Neil Derridj1,2, Daphné Madec3,2, Olivier Raisky3,2
1M3C-Necker, Unité Médico-Chirurgicale de Cardiologie Congénitale et Pédiatrique, Hôpital Universitaire Necker-Enfants Malades, Paris, Île-de-France, France derridjneil@gmail.com.
Archives of disease in childhood
|November 13, 2025
概括
心力衰竭是患有先天性或获得性心脏病 (CAHD) 的儿童的主要死亡原因,特别是在复杂先天性心脏病 (CHD) 和早产婴儿的第一年内.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 心血管研究研究心血管研究
- 死亡率研究 死亡率研究
背景情况:
- 遗传性或获得性心脏病 (CAHD) 在儿童中具有显著的死亡风险.
- 了解特定的死亡原因对于改善儿科心脏护理结果至关重要.
研究的目的:
- 详细介绍CAHD的儿科患者死亡原因.
- 更新不同CAHD分类中的死亡率数据.
主要方法:
- 从2010年到2024年在三级儿科心脏中心进行的前性观察队列研究.
- 死亡的CAHD儿童被分为先天性心脏病 (CHD),心肌病 (CM) 和肺高血压 (PH).
- 分析了整个队列和CAHD组的死亡原因和人口统计数据.
主要成果:
- 在患有CAHD的儿童中,心力衰竭是导致死亡的主要原因 (40.2%),其次是肺高血压 (PH) 危机 (11.8%) 和感染 (11.4%).
- 大多数死亡 (76.3%) 发生在患有心脏病的儿童中,严重复杂性和功能单管心脏是常见的.
- 大多数死亡 (72%) 是外科手术,显著比例需要体外膜氧化 (ECMO) 或心脏移植.
结论:
- 心力衰竭是儿童CAHD死亡的主要原因.
- 肺高血压和感染是导致死亡的重要因素.
- 死亡率在生命的第一年是最高的,特别是在复杂的心脏病和早产婴儿.
相关概念视频
Ischemic Heart Disease: Overview
2.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.8K
Coronary Artery Disease II: Pathophysiology
355
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
355
Heart Failure I: Introduction
671
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
671
Heart Failure II: Pathophysiology
695
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
695
Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
380
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
380


